HomeDMRA • NASDAQ
add
Damora Therapeutics Inc
Previous close
$24.27
Day range
$24.49 - $26.86
Year range
$16.50 - $29.22
Market cap
1.56B USD
Avg Volume
165.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.39M | 911.67% |
Net income | -200.74M | -2,877.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -27.38M | -913.32% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 257.62M | 1,717.45% |
Total assets | 260.53M | 1,420.70% |
Total liabilities | 20.15M | 1,448.58% |
Total equity | 240.38M | — |
Shares outstanding | 60.30M | — |
Price to book | -0.22 | — |
Return on assets | -50.48% | — |
Return on capital | -55.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -200.74M | -2,877.84% |
Cash from operations | 566.00K | 111.47% |
Cash from investing | -17.37M | — |
Cash from financing | 266.84M | — |
Net change in cash | 250.02M | 4,643.30% |
Free cash flow | 198.75K | 105.20% |
About
Founded
2011
Headquarters
Website
Employees
7
